Ashish Patel

Ashish Patel serves as the Senior Vice President of Sales and Marketing at Nanoscope Therapeutics Inc., leading the commercial launch of retinal gene therapy MCO-010 since March 2025. Prior to this role, Ashish was the Vice President of Sales for IZERVAY at Iveric Bio from September 2021 to July 2024, where responsibilities included building and launching the sales function. Ashish also held various significant roles at Novartis, including Executive Director for BEOVU and Head of HCP Launch Marketing for brolucizumab. At Bayer, Ashish was instrumental as the Global Launch Lead for EYLEA and held positions in sales and brand management that positively impacted P&L. Earlier experience includes serving as a Senior Scientist in R&D at Novartis Pharmaceuticals. Ashish holds an MBA in Finance, Entrepreneurship, and Innovation from NYU Stern School of Business and a PhD in Physiology and Biophysics from Stony Brook University.